Revisiting Antiangiogenic Multikinase Inhibitors in the Era of Immune Checkpoint Blockade: The Case of Sorafenib
Dan G. Duda, Rakesh K. Jain
Research output: Contribution to journal › Article › peer-review
13
Link opens in a new tab
Scopus
citations